MACROGEN, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19,640 KRW | +1.92% |
|
+2.13% | -6.48% |
| Jun. 12 | Lotte Card Teams Up With Macrogen for Genetic Testing Services | MT |
| 2023 | Tranche Update on Macrogen, Inc.'s Equity Buyback Plan announced on October 21, 2022. | CI |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 291,718 | 193,743 | 209,560 | 195,989 | - | - |
| Enterprise Value (EV) 2 | 291.7 | 181.6 | 220.9 | 231 | 225.1 | 212 |
| P/E ratio | 259 x | -9.62 x | -12.5 x | -126 x | 17.6 x | 13.7 x |
| Yield | - | 1.57% | 1.43% | 1.53% | 1.53% | 1.53% |
| Capitalization / Revenue | - | 1.4 x | 1.58 x | 1.43 x | 1.23 x | 1.03 x |
| EV / Revenue | - | 1.31 x | 1.66 x | 1.69 x | 1.42 x | 1.11 x |
| EV / EBITDA | - | 11.2 x | 31 x | 12.2 x | 8.62 x | 5.89 x |
| EV / FCF | - | -24.4 x | -11.9 x | -46.2 x | - | 23.6 x |
| FCF Yield | - | -4.1% | -8.44% | -2.16% | - | 4.25% |
| Price to Book | - | 1.07 x | 1.32 x | 1.36 x | 1.24 x | 1.06 x |
| Nbr of stocks (in thousands) | 9,889 | 10,117 | 9,979 | 9,979 | - | - |
| Reference price 3 | 29,500 | 19,150 | 21,000 | 19,640 | 19,640 | 19,640 |
| Announcement Date | 3/23/22 | 2/16/23 | 2/15/24 | - | - | - |
1KRW in Million2KRW in Billions3KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net sales 1 | - | 138.6 | 132.8 | 137 | 158.9 | 191 |
| EBITDA 1 | - | 16.26 | 7.131 | 19 | 26.1 | 36 |
| EBIT 1 | - | 5.293 | -0.5032 | 6.7 | 12 | 21 |
| Operating Margin | - | 3.82% | -0.38% | 4.89% | 7.55% | 10.99% |
| Earnings before Tax (EBT) 1 | - | -25.94 | -8.271 | -1.9 | 15.2 | 19 |
| Net income 1 | 1.112 | -20.01 | -6.879 | -2.1 | 12.1 | 15 |
| Net margin | - | -14.44% | -5.18% | -1.53% | 7.61% | 7.85% |
| EPS 2 | 114.0 | -1,990 | -1,683 | -156.0 | 1,116 | 1,433 |
| Free Cash Flow 3 | - | -7,450 | -18,635 | -5,000 | - | 9,000 |
| FCF margin | - | -5,374.3% | -14,032.17% | -3,649.64% | - | 4,712.04% |
| FCF Conversion (EBITDA) | - | - | - | - | - | 25,000% |
| FCF Conversion (Net income) | - | - | - | - | - | 60,000% |
| Dividend per Share 2 | - | 300.0 | 301.3 | 300.0 | 300.0 | 300.0 |
| Announcement Date | 3/23/22 | 2/16/23 | 2/15/24 | - | - | - |
1KRW in Billions2KRW3KRW in Million
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 29.74 | 35.55 | 38.04 | - | 36.92 | 31.64 | 32.1 | 35.1 | 38.1 |
| EBITDA | - | - | - | - | - | - | - | - | - | - |
| EBIT 1 | - | 0.6388 | 0.122 | 1.632 | - | 1.573 | - | 2.3 | 2.3 | 3.4 |
| Operating Margin | - | 2.15% | 0.34% | 4.29% | - | 4.26% | - | 7.17% | 6.55% | 8.92% |
| Earnings before Tax (EBT) 1 | - | - | - | - | - | - | - | 2.5 | 1.9 | -4 |
| Net income 1 | 0.1621 | -4.994 | - | - | -1.977 | -13.48 | -2.151 | 2.3 | 1.7 | -4 |
| Net margin | - | -16.79% | - | - | - | -36.51% | -6.8% | 7.17% | 4.84% | -10.5% |
| EPS | 50.00 | - | - | - | -198.0 | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 5/16/22 | 8/16/22 | 11/14/22 | 2/16/23 | 11/14/23 | 2/15/24 | 5/16/24 | - | - | - |
1KRW in Billions
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | 11.3 | 35 | 29.1 | 16 |
| Net Cash position 1 | - | 12.2 | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | 1.586 x | 1.842 x | 1.115 x | 0.4444 x |
| Free Cash Flow 2 | - | -7,450 | -18,635 | -5,000 | - | 9,000 |
| ROE (net income / shareholders' equity) | - | -10.3% | -3.92% | -1.1% | 7.4% | 8.3% |
| ROA (Net income/ Total Assets) | - | -7.81% | -6.25% | - | 4.4% | 6.7% |
| Assets 1 | - | 256.2 | 110 | - | 275 | 223.9 |
| Book Value Per Share 3 | - | 17,826 | 15,934 | 14,473 | 15,886 | 18,520 |
| Cash Flow per Share 3 | - | 1,070 | 477.0 | 2,884 | 4,665 | 5,187 |
| Capex 1 | - | 18.2 | 23.4 | 23 | 23 | 23 |
| Capex / Sales | - | 13.14% | 17.62% | 16.79% | 14.47% | 12.04% |
| Announcement Date | 3/23/22 | 2/16/23 | 2/15/24 | - | - | - |
1KRW in Billions2KRW in Million3KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
19,640
KRW
Average target price
27,000
KRW
Spread / Average Target
+37.47%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -6.48% | 143M | |
| +22.10% | 46.55B | |
| +46.45% | 41.84B | |
| -3.12% | 40.84B | |
| +36.10% | 32.95B | |
| -6.30% | 28.27B | |
| +18.71% | 27.78B | |
| +46.15% | 14.26B | |
| +44.52% | 13.69B | |
| +0.19% | 12.18B |
- Stock Market
- Equities
- A038290 Stock
- Financials Macrogen, Inc.
